Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to GM-CSF
Related studies linked through entity extraction aliases.
NB2013-HR German (GPOH) / Dutch (DCOG) Trial
- Status
- TERMINATED
- Phase
- PHASE2
Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma
- Status
- COMPLETED
- Phase
- PHASE4
A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF
- Status
- COMPLETED
- Phase
- PHASE1
Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effects of Embryogen in RIF Patients
- Status
- COMPLETED
- Phase
- PHASE4
Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)
- Status
- UNKNOWN
- Phase
- PHASE2
Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Therapy for Children With Advanced Stage Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
- Status
- COMPLETED
- Phase
- PHASE2
Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE2